Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-17-011354
Filing Date
2017-11-03
Accepted
2017-11-03 17:04:30
Documents
10
Effectiveness Date
2017-11-03

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS defa14a110317_chinapharma.htm DEFA14A 100657
2 GRAPHIC proxy_001.jpg GRAPHIC 1833
3 GRAPHIC proxy_002.jpg GRAPHIC 1545
4 GRAPHIC proxy_003.jpg GRAPHIC 1399
5 GRAPHIC proxy_004.jpg GRAPHIC 2117
6 GRAPHIC proxy_005.jpg GRAPHIC 6975
7 GRAPHIC image_001.jpg GRAPHIC 1273
8 GRAPHIC image_002.jpg GRAPHIC 1375
9 GRAPHIC image_003.jpg GRAPHIC 1237
10 GRAPHIC image_004.jpg GRAPHIC 1169
  Complete submission text file 0001213900-17-011354.txt   129303
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

EIN.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1230
Type: DEFA14A | Act: 34 | File No.: 001-34471 | Film No.: 171177314
SIC: 2834 Pharmaceutical Preparations